Literature DB >> 15714005

Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome.

Chikashi Nakanishi1, Tatsuro Yamaguchi, Takeru Iijima, Shigehira Saji, Masakazu Toi, Takeo Mori, Michiko Miyaki.   

Abstract

Peutz-Jeghers syndrome (PJS) is an autosomal-dominant polyposis disorder with an increased risk of multiple cancer. The LKB1/STK11 gene, which acts as a tumor suppressor, is responsible for PJS and plays a role in suppressing breast cancer. The low expression of LKB1/STK11 in sporadic breast cancer is significantly associated with shorter survival. Here we describe a PJS patient with aggressive breast cancer that carried not only a germline mutation of LKB1/STK11 but also loss of the normal allele. The combination of these mutations may be associated with the poor prognosis of this patient. To our knowledge, we are the first to show that a germline mutation causing PJS is combined with the loss of the homologous normal allele of LKB1/STK11 in breast cancer. Copyright (c) 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15714005     DOI: 10.1159/000082933

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  14 in total

1.  Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.

Authors:  Kathryn J Ruddy; Betsy C Risendal; Judy E Garber; Ann H Partridge
Journal:  J Clin Oncol       Date:  2015-12-28       Impact factor: 44.544

2.  AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia.

Authors:  Jeffim N Kuznetsov; Guy J Leclerc; Gilles M Leclerc; Julio C Barredo
Journal:  Mol Cancer Ther       Date:  2011-01-24       Impact factor: 6.261

Review 3.  Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.

Authors:  Mukesh Verma; Daniela Seminara; Fernando J Arena; Christy John; Kumiko Iwamoto; Virginia Hartmuller
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

4.  Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.

Authors:  Sofia Theodoropoulou; Paraskevi E Kolovou; Yuki Morizane; Maki Kayama; Fotini Nicolaou; Joan W Miller; Evangelos Gragoudas; Bruce R Ksander; Demetrios G Vavvas
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

Review 5.  Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers.

Authors:  Jennifer L Herrmann; Yevgeniya Byekova; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2011-03-29       Impact factor: 8.679

Review 6.  The mTOR pathway in breast cancer.

Authors:  Nancy E Hynes; Anne Boulay
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

7.  LKB1 catalytic activity contributes to estrogen receptor alpha signaling.

Authors:  Suchita Nath-Sain; Paola A Marignani
Journal:  Mol Biol Cell       Date:  2009-04-15       Impact factor: 4.138

8.  Novel serine/threonine kinase 11 gene mutations in Peutz-Jeghers syndrome patients and endoscopic management.

Authors:  Hiroyuki Yajima; Hajime Isomoto; Hiroaki Nishioka; Naoyuki Yamaguchi; Ken Ohnita; Tatsuki Ichikawa; Fuminao Takeshima; Saburo Shikuwa; Masahiro Ito; Kazuhiko Nakao; Kazuhiro Tsukamoto; Shigeru Kohno
Journal:  World J Gastrointest Endosc       Date:  2013-03-16

9.  CoQ10 and endothelial function in Asians from Korea compared to Asians born in the United States and US born Caucasians.

Authors:  Jerrold Scott Petrofsky; Michael Laymon; Haneul Lee; Jong Yim; Erin Harnandez; Donny Dequine; Lindsay Thorsen; Kennith Lovell; Joshua Andrade
Journal:  Med Sci Monit       Date:  2013-05-06

10.  Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis.

Authors:  Sofia Theodoropoulou; Katarzyna Brodowska; Maki Kayama; Yuki Morizane; Joan W Miller; Evangelos S Gragoudas; Demetrios G Vavvas
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.